Skip to main content
. 2019 May 1;35(5):733–742. doi: 10.1007/s00467-019-04241-7

Fig. 4.

Fig. 4

Factors that influence the progression of Alport syndrome. Treatments that have confirmed or proposed effects on protecting kidney function, cardiovascular risk and hearing (top half in green) and factors that are known or thought to be deleterious (bottom half in blue). ACE angiotensin-converting enzyme, ARB angiotensin receptor blocker, HMG-CoA β-hydroxy β-methylglutaryl-CoA, NSAIDs non-steroidal anti-inflammatory drugs